Leonteq Securities’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
Leonteq Securities's HRMY Position: Q3 2026 in Review
Leonteq Securities increased its Harmony Biosciences (HRMY) stake by 44% in Q3 2026, buying an estimated $13.5K and bringing the position to 1,150 shares worth $45.1K. The position accounts for ﹤0.01% of the portfolio, ranked #796.
Leonteq Securities first reported a position in HRMY in Q4 2021 and has held it in 17 quarters since. The position peaked at $80.8K in Q2 2023. 285 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- Leonteq Securities held 1,150 shares of Harmony Biosciences worth $45.1K as of Q3 2026.
- Leonteq Securities bought 350 Harmony Biosciences shares in Q3 2026, an estimated $13.5K.
- Harmony Biosciences made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #796 holding.
- Leonteq Securities first reported a position in Harmony Biosciences in Q4 2021 and has held it in 17 quarters since.
- Leonteq Securities's Harmony Biosciences position peaked at $80.8K in Q2 2023.
- 285 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.